Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Robinson

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|May 29, 2003
Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imagingS P Robinson, D J O McIntyre, D Checkley, et al.
British Journal of Cancer|August 15, 2013
Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRIM Beloueche-Babari, Y Jamin, V Arunan, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Influence of estradiol and tamoxifen on susceptibility of human breast cancer cell lines to lysis by lymphokine-activated killer cellsM R Albertini, D F Gibson, S P Robinson, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumoursP M J McSheehy, R E Port, L M Rodrigues, et al.
Bone Marrow Transplantation|January 16, 2021
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trialR Pettengell, R Uddin, A Boumendil, et al.
Bone Marrow Transplantation|June 22, 2005
Early emergence of PNH-like T cells after allogeneic stem cell transplants utilising CAMPATH-1H for T cell depletionR J Garland, S J Groves, P Diamanti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†S P Robinson, A Boumendil, H Finel, et al.
Disease Models & Mechanisms|August 3, 2016
The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCNJ Guan, E R Tucker, H Wan, et al.
The Plant Journal : for Cell and Molecular Biology|September 29, 2001
Construct design for efficient, effective and high-throughput gene silencing in plantsS V Wesley, C A Helliwell, N A Smith, et al.
Bone Marrow Transplantation|December 1, 2015
Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working PartyS P Robinson, A Boumendil, H Finel, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|May 29, 2003
Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imagingS P Robinson, D J O McIntyre, D Checkley, et al.
British Journal of Cancer|August 15, 2013
Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRIM Beloueche-Babari, Y Jamin, V Arunan, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Influence of estradiol and tamoxifen on susceptibility of human breast cancer cell lines to lysis by lymphokine-activated killer cellsM R Albertini, D F Gibson, S P Robinson, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumoursP M J McSheehy, R E Port, L M Rodrigues, et al.
Bone Marrow Transplantation|January 16, 2021
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trialR Pettengell, R Uddin, A Boumendil, et al.
Bone Marrow Transplantation|June 22, 2005
Early emergence of PNH-like T cells after allogeneic stem cell transplants utilising CAMPATH-1H for T cell depletionR J Garland, S J Groves, P Diamanti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†S P Robinson, A Boumendil, H Finel, et al.
Disease Models & Mechanisms|August 3, 2016
The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCNJ Guan, E R Tucker, H Wan, et al.
The Plant Journal : for Cell and Molecular Biology|September 29, 2001
Construct design for efficient, effective and high-throughput gene silencing in plantsS V Wesley, C A Helliwell, N A Smith, et al.
Bone Marrow Transplantation|December 1, 2015
Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working PartyS P Robinson, A Boumendil, H Finel, et al.
Pageof 15